Mastiplan LC
ATC code
Species
Cattle (lactating cows)
Indications
Treatment of clinical mastitis in lactating dairy cows caused by Staphylococcus aureus, coagulase-negative staphylococci, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus uberis and Escherichia coli sensitive to cefapirin.
Dose to be administered and administration route
For intramammary use:
The contents of one syringe should be infused into each affected quarter via the teat canal, immediately after milking, at 12 hour intervals for four consecutive milkings.
Each syringe contains 300 mg cefapirin and 20 mg prednisolone. The syringe must only be used once for one teat.
Before infusion, the udder should be milked out completely. The teat and its orifice should be thoroughly cleaned and disinfected with the cleaning towel provided (A).
Care should be taken to avoid contamination of the syringe nozzle. Break the top of cap and gently insert either about 5 mm (B) or remove whole cap and gently insert the total length of the nozzle (C) into the teat canal. Infuse the total content of the syringe into the quarter.
Disperse the product by gentle massage of the teat and the udder of the affected cow.
Adverse reactions
Cattle (Lactating cows):
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Hypersensitivity reaction |
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also ‘Contact details’ of the package leaflet.
